TRK-820, a Selective κ-Opioid Agonist, Produces Potent Antinociception in Cynomolgus Monkeys
Open Access
- 1 January 2001
- journal article
- research article
- Published by Elsevier in The Japanese Journal of Pharmacology
- Vol. 85 (3) , 282-290
- https://doi.org/10.1254/jjp.85.282
Abstract
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societiesKeywords
This publication has 9 references indexed in Scilit:
- Characterization of the antinociceptive effects of TRK-820 in the ratEuropean Journal of Pharmacology, 2000
- Potent antinociceptive effects of TRK-820, a novel κ-opioid receptor agonistLife Sciences, 1999
- Pharmacological properties of TRK-820 on cloned μ-, δ- and κ-opioid receptors and nociceptin receptorEuropean Journal of Pharmacology, 1999
- Discovery of a Structurally Novel Opioid .KAPPA.-Agonist Derived from 4,5-Epoxymorphinan.CHEMICAL & PHARMACEUTICAL BULLETIN, 1998
- Blockade of morphine reward through the activation of κ-opioid receptors in miceNeuropharmacology, 1993
- Binaltorphimine and nor-binaltorphimine, potent and selective k-opioid receptor antagonistsLife Sciences, 1987
- A tail withdrawal procedure for assessing analgesic activity in rhesus monkeysJournal of Pharmacological Methods, 1986
- Behavioral effects of a novel kappa opioid analgesic, U-50488, in rats and rhesus monkeysPsychopharmacology, 1985